Rallybio Reports $2.73 Million Net Loss for 2026
Rallybio reported no revenue and a net loss of $2.73 million in 2026, compared with revenue of $212,000 and net income of $16.02 million in the prior-year period. Diluted loss per share was $0.48, versus earnings per share of $2.84.